Focusing on non-psychiatric patients with metabolic disturbances, numerous clinical studies have shown that dysregulated leptin and adiponectin levels (38, 39) are strongly associated with dyslipidemia. The gene discussed is ADIPOQ; the disease is metabolic syndrome.